10,975
Total Claims
$1.8M
Drug Cost
650
Beneficiaries
$2,722
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-55%
Opioid rate vs peers
1.1% vs 2.6% avg
+155%
Cost per patient vs peers
$2,722 vs $1,068 avg
+67%
Brand preference vs peers
15.0% vs 9.0% avg
Opioid Prescribing
1.1%
Opioid Rate
126
Opioid Claims
$5,971
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 1,636 claims · $1.5M
Generic: 9,248 claims · $241K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 142 | $208K |
| Semaglutide | 78 | $166K |
| Dulaglutide | 141 | $158K |
| Sitagliptin Phosphate | 105 | $135K |
| Semaglutide | 103 | $133K |
| Linaclotide | 95 | $92K |
| Apixaban | 71 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 69 | $53K |
| Elviteg/Cob/Emtri/Tenof Alafen | 13 | $53K |
| Empagliflozin/Metformin Hcl | 33 | $42K |
| Linagliptin | 29 | $39K |
| Dapagliflozin Propanediol | 27 | $36K |
| Dapaglifloz Propaned/Metformin | 21 | $32K |
| Empagliflozin/Metformin Hcl | 14 | $26K |
| Tiotropium Br/Olodaterol Hcl | 36 | $21K |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data